Jing Bao, MD, PhD

Dr. Jing Bao is a Partner at Shanghai HealthCare Capital (SHC). A physician-scientist with a PhD from the Weizmann Institute of Science, Dr. Bao possesses extensive experience in life science investment, patient care, drug development, clinical research and regulation. Dr. Bao also holds the position of Adjunct Professor at the China Infectious Diseases Clinical Center at Fudan University and a senior physician from China, Dr. Bao earned her MD from Southeastern University in Nanjing and her PhD was under the supervision of Professor Yosef Yarden, a world-renowned cancer researcher who received the Israel Prize in 2017. Subsequently, Dr. Bao worked for 14 years at the National Institute of Health (NIH) in the United States, where she also directed and managed NIH’s global clinical trial projects in the field of infectious diseases. Dr. Bao has published in leading scientific journals and has made over 100 presentations in more than 20 countries. Before her current position, Dr. Bao also served as the Chief Medical Officer for large pharmaceutical and biotech companies.

Dr. Bao is the author of two books aimed at promoting friendship and global understanding. Additionally, she serves as a board member for two companies: Neomics Therapeutics in the United States and Biomica Ltd in Rehovot, Israel.